| Product Code: ETC7181997 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to rely on key suppliers such as Australia, New Zealand, India, Bangladesh, and the USA for its oral hypoglycemic agents (OHAs) imports. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained high, indicating a dominant presence of these top exporting countries. Despite a healthy compound annual growth rate (CAGR) of 6.89% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -15.21%. This fluctuation suggests potential market challenges or shifts in demand dynamics impacting the importation of OHAs in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Fiji Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2021 & 2031F |
3.6 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Fiji Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Fiji |
4.2.2 Growing awareness about the importance of managing diabetes |
4.2.3 Advancements in oral hypoglycemic agents technology |
4.3 Market Restraints |
4.3.1 High cost associated with oral hypoglycemic agents |
4.3.2 Limited access to healthcare services in remote areas of Fiji |
4.3.3 Stringent regulatory requirements for drug approval |
5 Fiji Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Fiji Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Fiji Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2021- 2031F |
6.1.3 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
6.1.4 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2021- 2031F |
6.1.5 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2021- 2031F |
6.1.6 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2021- 2031F |
6.2 Fiji Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Fiji Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Fiji Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Fiji Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Number of diabetic patients using oral hypoglycemic agents in Fiji |
8.2 Rate of adoption of new oral hypoglycemic agents in the market |
8.3 Patient satisfaction and compliance with oral hypoglycemic agents |
8.4 Number of healthcare providers prescribing oral hypoglycemic agents |
8.5 Research and development investment in oral hypoglycemic agents technology |
9 Fiji Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Fiji Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2021 & 2031F |
9.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Fiji Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Fiji Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2024 |
10.2 Fiji Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |